During Winter Olympics, UNAIDS calls on Canada to ensure G8 delivers on universal access

World leaders in HIV research, health, innovation and policy shared latest and compelling perspectives on the challenges being faced under a shifting global health paradigm.

READ MORE

Leave a Reply

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025